SECsense Logo

Aptose Biosciences Inc. 8-K Filing: Key Updates & Insights (Feb 2025)

$APTO
Form 8-K
Filed on: 2025-02-12
Source
Aptose Biosciences Inc. 8-K Filing: Key Updates & Insights (Feb 2025)

From the extracted financial report section, here are the key insights:

  1. Filing Type and Date:
  • The document is a Form 8-K, which is typically used to report major events that shareholders should know about.
  • The filing date is February 12, 2025.
  1. Entity Information:
  • The filing is by Aptose Biosciences Inc..
  • The company's CIK (Central Index Key) number is 0000882361.
  • The SEC file number is 001-32001.
  • The company's tax identification number (EIN) is 98-1136802.
  • The registered office is located at 66 Wellington Street West, Suite 5300 TD Bank Tower, Box 48, Toronto, ON M5K 1E6.
  • Contact number: 310-849-8060.
  1. Securities Information:
  • The company has Common Shares with no par value.
  • The trading symbol for Aptose Biosciences is APTO on the NASDAQ.
  1. Context and Units:
  • The report uses USD as the reporting currency and shares as the unit of measure.
  • The report structure indicates that it may include financial data relevant to share performance or other specific metrics expressed in USD per share.
  1. Regulatory Compliance:
  • The document adheres to the XBRL (eXtensible Business Reporting Language) standards for SEC filings, indicating structured and machine-readable reporting.

Overall, this report appears to be a routine filing by Aptose Biosciences to disclose important company information to the SEC and its shareholders, relevant to the date indicated. Further details would be necessary for deeper financial insights or to understand specific events being reported.